1652 — Fusen Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$584.05m
- HK$848.02m
- CNY273.37m
Brief: Fusen Pharmaceutical Announces Acquisition Of 34% Stake In Weihai Rensheng Pharmaceutical Group
Brief: Fusen Pharmaceutical Company Sees HY Profit Attributable Increase By Not Less Than 40%
Brief: Fusen Pharmaceutical Company Sees Decrease In Profit Attributable For Fy2019 By Over 45%
Brief: Fusen Pharmaceutical Co Says Co Has Not Carried Out Research Activities On Effectiveness Of Drug For Inhibiting Novel Coronavirus
Brief: Fusen Pharmaceutical Announces Capital Injection Deal Into Jiangxi Kangde
Brief: Fusen Pharmaceutical Company Sees A Decline Of Over 40% In HY Profit Attributable
Brief: Fusen Pharmaceutical Company Announces Acquisition Of State-Owned Land Use For RMB132.6 Mln
Brief: Fusen Pharmaceutical Co Appoints Li Zhen As CFO
Brief: Fusen Pharmaceutical Posts FY Profit Attributable RMB101.9 Mln
Brief: Fusen Pharmaceutical Co Says Unit To Inject Capital Of RMB26.0 Mln Into Target Co
Brief: Fusen Pharmaceutical Company Posts HY Profit Attributable Of RMB53.5 Mln